Document is current
Any future updates will be listed below
-
Authors
Ryan, Danielle
Reback, Cathy J.
Mata, Raymond P.
Li, Michael
Jalali, Ali
Jeng, Philip J.
Benkeser, David
Murphy, Sean M.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA056888)
National Institute on Drug Abuse (R01DA056888)
National Institute on Drug Abuse (R01DA056888)
National Institute on Drug Abuse (R01DA056888)
National Institute on Drug Abuse (P30DA040500)
National Institute on Drug Abuse (R01DA056888)
National Institute on Drug Abuse (R01DA056888)
National Institute on Drug Abuse (P30DA040500)
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 21 April 2026
First Online: 4 May 2026
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and the trial, and its procedures have been approved by the Western Institutional Review Board (#20224309), which serves as the IRB of record for all participating institutions and subject recruitment venues. The study was registered on 05/23/23 as a clinical trial (Clinical Trials #NCT05934877).
: Participation was voluntary and were consented. Participants could withdraw anytime without penalty.
: Not applicable.
: The authors declare no competing interests.
